Selectis Health, INC 10-Q quarterly reports

Selectis Health reports a net income of $6.5 million for Q1 2026, driven primarily by asset sales, despite ongoing going concern uncertainties.

Selectis Health, Inc. reported a significant reduction in net loss for the nine months ended September 30, 2025, and a swing to net income for the third quarter, driven by increased healthcare revenue and employee retention credits, despite ongoing liquidity concerns and internal control weaknesses.

Selectis Health, Inc. reported a widened net loss and significant liquidity challenges for Q2 2025, raising substantial doubt about its ability to continue as a going concern.

Selectis Health saw a revenue increase in Q1 2025, but continues to face net losses and substantial doubt about its ability to continue as a going concern.

Selectis Health's Q3 2024 results show a net loss and negative operating cash flow, raising concerns about the company's ability to continue as a going concern, despite increased healthcare revenue.

Selectis Health saw an increase in healthcare revenue for Q2 2024, but continues to face challenges related to internal controls and a going concern warning.

Selectis Health's Q1 2024 results show stable revenue but a net loss, with management expressing concerns about the company's ability to continue as a going concern.